source
- GSK to invest $800 million in new biologics manufacturing hub in PennsylvaniaGSK announced it will spend more than $800 million to expand its Upper Merion site near Philadelphia, adding biologics production capacity. The plan includes demolishing existing structures next y…
- Integrating Multiple Stability Measurements Improves Early Biologics TestingJohn Stenson of Malvern Panalytical argues that combining several stability assays on a single platform can increase both throughput and data quality for early‑stage biologics development. He note…